Throughout the history of medicine, drug developers have tried to make clinical trials faster and more efficient. Artificial intelligence and machine-learning methods are some of the newer approaches ...

In the pulsating world of Hip Hop, UnLearn The World is carving a niche for himself with his latest offering, “The God That Sins.” An in-depth conversation with the artist reveals the inspiration, ...

Unlearn and Merck KGaA have announced a partnership to accelerate drug trials using medical digital twins of patients. Unlearn uses recent developments from deep learning to create digital twins of ...

Patient-level digital twins expected to strengthen evidence generation in Phase1/2 clinical study evaluating VTx-002, a first-in-class vectorized antibody targeting TDP-43 pathology in patients with ...

March 21 (Reuters) - Unlearn.AI, which has built a machine learning platform that creates "digital twin" profiles of patients in clinical trials, has raised $15 million to expand partnerships and ...

Kwame Marfo brings more than 15 years of experience at the intersection of life sciences, health technology, and product innovation SAN FRANCISCO, July 29, 2025--(BUSINESS WIRE)--Unlearn®, a leader in ...

SAN FRANCISCO--(BUSINESS WIRE)--Unlearn®, developer of the first machine-learning platform that creates Digital Twins used to populate Intelligent Control Arms in clinical studies, today announced ...

Twins have long played a role in the world of medical research, specifically in the area of clinical trials, where they can help measure the effectiveness of a therapy by applying a control to one of ...

SAN FRANCISCO--(BUSINESS WIRE)--Unlearn.AI, developer of the first machine-learning platform that creates Digital Twins used to populate Intelligent Control Arms in clinical studies, today announced ...